Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Mol Cancer Ther. 2012 Jun 29;11(9):2054–2061. doi: 10.1158/1535-7163.MCT-12-0221

Table 1.

The relationships among rs1649942, miRNAs, mRNAs and cellular sensitivity to platinum agents in the HapMap CEU discovery samples.

rs1649942 association with platinum IC50P value miRNA rs1649942-miR association p value miRNA P value association with platinum IC50 gene P values


carboplatin cisplatin Carboplatin cisplatin rs16499 42-gene Gene-carboplatin Gene-cisplatin miRNA-gene
1E-5 7E-5 miR-193b* 3.4E-3 7.3E-3 1.6E-2 CRIM1 3E-5 1.0E-4 9.8E-4 2.8E-5

IFIT2 1E-4 1.8E-2 7.6E-3 6.3E-5

OAS1 1E-5 3.7E-2 4.3E-2 5.2E-5

CCR6 5E-5 3.3E-2 2.0E-2 3.1E-4

3.5E-4 1.5E-4

CYP2R1 1E-4 3.3E-4 2.5E-3 2.0E-2

1E-4 2.2E-5 1.9E-3 2.7E-3

KYNU 9E-6 9.3E-4 2.7E-4 4.8E-3

RAPGEF5 2E-6 2.0E-2 4.6E-2 1.0E-2

SLC2A5 2E-5 6.1E-3 1.5E-3 6.6E-3

USP12 9E-5 5.1E-4 4.2E-4 1.3E-3

ZHX12 7E-5 1.2E-5 6.2E-5 2.0E-2

miR-320a 4.5E-2 1.0E-2 3.7E-2 GRAMD1B 1E-4 4.7E-4 4.4E-3 3.5E-5

KCNMA1 7E-5 2.4E-2 3.4E-2 9.1E-5

PSTPIP2 2E-5 1.6E-4 7.1E-4 1.9E-3

miR-424 6.7E-3 2.4E-2 2.7E-2 GRAMD1B 1E-4 4.7E-4 4.4E-3 5.9E-3

KCNMA1 7E-5 2.4E-2 3.4E-2 9.8E-3

PSTPIP2 2E-5 1.6E-4 7.1E-4 2.0E-2

SHFM3P1 2E-6 2.8E-3 1.2E-2 4.0E-2

4E-5

Bold miRNA and gene pairs meet negative correlation and p<10−4 cutoff and were evaluated in replication samples.